These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33232671)

  • 1. Addicted to Acidic Microenvironment.
    Hongu T; Oskarsson T
    Dev Cell; 2020 Nov; 55(4):381-382. PubMed ID: 33232671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Oncogenic PRL Protein Causes Acid Addiction of Cells by Stimulating Lysosomal Exocytosis.
    Funato Y; Yoshida A; Hirata Y; Hashizume O; Yamazaki D; Miki H
    Dev Cell; 2020 Nov; 55(4):387-397.e8. PubMed ID: 32918875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRL3 promotes cell invasion and proliferation by down-regulation of Csk leading to Src activation.
    Liang F; Liang J; Wang WQ; Sun JP; Udho E; Zhang ZY
    J Biol Chem; 2007 Feb; 282(8):5413-9. PubMed ID: 17192274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction with tumor‑associated macrophages promotes PRL‑3‑induced invasion of colorectal cancer cells via MAPK pathway‑induced EMT and NF‑κB signaling‑induced angiogenesis.
    Zhang T; Liu L; Lai W; Zeng Y; Xu H; Lan Q; Su P; Chu Z
    Oncol Rep; 2019 May; 41(5):2790-2802. PubMed ID: 30864736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRL‑3 increases the aggressive phenotype of prostate cancer cells in vitro and its expression correlates with high-grade prostate tumors in patients.
    Edwards DR; Moroz K; Zhang H; Mulholland D; Abdel-Mageed AB; Mondal D
    Int J Oncol; 2018 Feb; 52(2):402-412. PubMed ID: 29207031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of GATA zinc finger domain containing 1 through gene amplification promotes liver cancer by directly inducing phosphatase of regenerating liver 3.
    Sun W; Zhang Y; Wong KC; Liu K; Yang Y; Wu B; Tong JHM; Chan AWH; Chan HLY; Yu J
    Hepatology; 2018 Jun; 67(6):2302-2319. PubMed ID: 29266303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of phosphatase regenerating liver 3 in oesophageal squamous cell carcinoma associated with metastasis and its comparison with phosphatase regenerating liver 1.
    Lou X; Liu Y; Lei JY; Li H
    Cell Biol Int; 2012 Aug; 36(8):759-63. PubMed ID: 22551255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy induced PRL3 expression promotes cancer growth via plasma membrane remodeling and specific alterations of caveolae-associated signaling.
    Csoboz B; Gombos I; Tatrai E; Tovari J; Kiss AL; Horvath I; Vigh L
    Cell Commun Signal; 2018 Aug; 16(1):51. PubMed ID: 30157875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRL3 phosphatase active site is required for binding the putative magnesium transporter CNNM3.
    Zhang H; Kozlov G; Li X; Wu H; Gulerez I; Gehring K
    Sci Rep; 2017 Mar; 7(1):48. PubMed ID: 28246390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNAi‑mediated knockdown of PRL‑3 inhibits cell invasion and downregulates ERK 1/2 expression in the human gastric cancer cell line, SGC‑7901.
    Cao Y; Tu Y; Mei J; Li Z; Jie Z; Xu S; Xu L; Wang S; Xiong Y
    Mol Med Rep; 2013 Jun; 7(6):1805-11. PubMed ID: 23589069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRL3-zumab, a first-in-class humanized antibody for cancer therapy.
    Thura M; Al-Aidaroos AQO; Yong WP; Kono K; Gupta A; Lin YB; Mimura K; Thiery JP; Goh BC; Tan P; Soo R; Hong CW; Wang L; Lin SJ; Chen E; Rha SY; Chung HC; Li J; Nandi S; Yuen HF; Zhang SD; Guan YK; So J; Zeng Q
    JCI Insight; 2016 Jun; 1(9):e87607. PubMed ID: 27699276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological and oncogenic roles of the PRL phosphatases.
    Hardy S; Kostantin E; Hatzihristidis T; Zolotarov Y; Uetani N; Tremblay ML
    FEBS J; 2018 Nov; 285(21):3886-3908. PubMed ID: 29770564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of protein phosphatases in the cancer microenvironment.
    Ruvolo PP
    Biochim Biophys Acta Mol Cell Res; 2019 Jan; 1866(1):144-152. PubMed ID: 30026077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phosphatase of regenerating liver-3 (PRL-3) and tumor metastasis].
    Peng LR; Shou CC
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):1-3. PubMed ID: 17575683
    [No Abstract]   [Full Text] [Related]  

  • 15. Phosphatase of regenerating liver-3 promotes migration and invasion by upregulating matrix metalloproteinases-7 in human colorectal cancer cells.
    Lee SK; Han YM; Yun J; Lee CW; Shin DS; Ha YR; Kim J; Koh JS; Hong SH; Han DC; Kwon BM
    Int J Cancer; 2012 Aug; 131(3):E190-203. PubMed ID: 22131018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory mechanisms of phosphatase of regenerating liver (PRL)-3.
    Rubio T; Köhn M
    Biochem Soc Trans; 2016 Oct; 44(5):1305-1312. PubMed ID: 27911713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A selective phosphatase of regenerating liver phosphatase inhibitor suppresses tumor cell anchorage-independent growth by a novel mechanism involving p130Cas cleavage.
    Daouti S; Li WH; Qian H; Huang KS; Holmgren J; Levin W; Reik L; McGady DL; Gillespie P; Perrotta A; Bian H; Reidhaar-Olson JF; Bliss SA; Olivier AR; Sergi JA; Fry D; Danho W; Ritland S; Fotouhi N; Heimbrook D; Niu H
    Cancer Res; 2008 Feb; 68(4):1162-9. PubMed ID: 18281492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Na+/H+ exchangers and RhoA regulate acidic extracellular pH-induced lysosome trafficking in prostate cancer cells.
    Steffan JJ; Snider JL; Skalli O; Welbourne T; Cardelli JA
    Traffic; 2009 Jun; 10(6):737-53. PubMed ID: 19302267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of phosphatase of regenerating liver-3 (PRL-3) in endometrioid cancer and lymph nodes metastases.
    Guzińska-Ustymowicz K; Kiśluk J; Terlikowski SJ; Pryczynicz A; Niewiarowska K; Ustymowicz M; Hawryluk M; Południewski M; Kemona A
    Adv Med Sci; 2013; 58(2):221-6. PubMed ID: 23729584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of the PRL phosphatases.
    Rios P; Li X; Köhn M
    FEBS J; 2013 Jan; 280(2):505-24. PubMed ID: 22413991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.